These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 14503801)

  • 1. Involvement of TGF-beta(s)/T(beta)Rs system in tumor progression of murine mammary adenocarcinomas.
    Daroqui MC; Puricelli LI; Urtreger AJ; Elizalde PV; Lanuza GM; Bal de Kier Joffé E
    Breast Cancer Res Treat; 2003 Aug; 80(3):287-301. PubMed ID: 14503801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of growth and metastasis of mouse mammary carcinoma by selective inhibitor of transforming growth factor-beta type I receptor kinase in vivo.
    Ge R; Rajeev V; Ray P; Lattime E; Rittling S; Medicherla S; Protter A; Murphy A; Chakravarty J; Dugar S; Schreiner G; Barnard N; Reiss M
    Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4315-30. PubMed ID: 16857807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of TGF-beta activity abrogates growth promoting tumor cell-cell interactions in vivo.
    Theodorescu D; Caltabiano M; Greig R; Rieman D; Kerbel RS
    J Cell Physiol; 1991 Sep; 148(3):380-90. PubMed ID: 1655815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factor-beta production and induction of cellular responses in 13762NF rat mammary adenocarcinoma cell clones.
    Kaufmann AM; Stoeck M; Schirrmacher V; Lichtner RB
    Invasion Metastasis; 1993; 13(5):244-52. PubMed ID: 7960577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptotic cell death in mammary adenocarcinoma cells is prevented by soluble factors present in the target organ of metastasis.
    Ladeda V; Adam AP; Puricelli L; Bal de Kier Joffé E
    Breast Cancer Res Treat; 2001 Sep; 69(1):39-51. PubMed ID: 11759827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GM-CSF secreted by murine adenocarcinoma cells modulates tumor progression and immune activity.
    Diament MJ; Stillitani MI; Puricelli L; Bal de Kier-Joffe E; Klein S
    Oncol Rep; 2003; 10(5):1647-52. PubMed ID: 12883753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor beta stimulates mammary adenocarcinoma cell invasion and metastatic potential.
    Welch DR; Fabra A; Nakajima M
    Proc Natl Acad Sci U S A; 1990 Oct; 87(19):7678-82. PubMed ID: 2217201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Varying patterns of expression of insulin-like growth factors I and II and their receptors in murine mammary adenocarcinomas of different metastasizing ability.
    Guerra FK; Eijan AM; Puricelli L; Alonso DF; Bal de Kier Joffé E; Kornblihgtt AR; Charreau EH; Elizalde PV
    Int J Cancer; 1996 Mar; 65(6):812-20. PubMed ID: 8631597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor beta1 stimulates contrasting responses in metastatic versus primary mouse prostate cancer-derived cell lines in vitro.
    Sehgal I; Baley PA; Thompson TC
    Cancer Res; 1996 Jul; 56(14):3359-65. PubMed ID: 8764134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of metastatic and invasive capacity of gastric cancer cells by transforming growth factor-beta1.
    Wang KS; Hu ZL; Li JH; Xiao DS; Wen JF
    Acta Biochim Biophys Sin (Shanghai); 2006 Mar; 38(3):179-86. PubMed ID: 16518542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of TGF-beta inhibits mammary tumor cell viability, migration, and metastases.
    Muraoka RS; Dumont N; Ritter CA; Dugger TC; Brantley DM; Chen J; Easterly E; Roebuck LR; Ryan S; Gotwals PJ; Koteliansky V; Arteaga CL
    J Clin Invest; 2002 Jun; 109(12):1551-9. PubMed ID: 12070302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor-beta differentially inhibits epithelial ovarian carcinoma cells from primary and metastatic isolates without up-regulation of p21WAF1.
    Hurteau JA; Allison B; Sutton GP; Moore DH; Look KY; Hurd W; Bigsby RM
    Cancer; 1999 Apr; 85(8):1810-5. PubMed ID: 10223576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of two hormone-responsive mouse mammary carcinoma cell lines derived from a metastatic mammary tumor.
    Efeyan A; Fabris V; Merani S; Lanari C; Molinolo AA
    Breast Cancer Res Treat; 2004 Feb; 83(3):233-44. PubMed ID: 14758093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor-beta1 inhibits tumor growth in a mouse melanoma model by down-regulating the plasminogen activation system.
    Ramont L; Pasco S; Hornebeck W; Maquart FX; Monboisse JC
    Exp Cell Res; 2003 Nov; 291(1):1-10. PubMed ID: 14597403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGF beta regulation of cell proliferation.
    Moses HL; Arteaga CL; Alexandrow MG; Dagnino L; Kawabata M; Pierce DF; Serra R
    Princess Takamatsu Symp; 1994; 24():250-63. PubMed ID: 8983080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of epidermal growth factor/transforming growth factor alpha and transforming growth factor beta 1 on growth in vitro of rat urinary bladder carcinoma cells.
    Kawamata H; Azuma M; Kameyama S; Nan L; Oyasu R
    Cell Growth Differ; 1992 Nov; 3(11):819-25. PubMed ID: 1467309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of three new mouse mammary tumor cell lines as models for transforming growth factor (TGF)-beta and Neu pathway signaling studies: identification of a novel model for TGF-beta-induced epithelial-to-mesenchymal transition.
    Lenferink AE; Magoon J; Cantin C; O'Connor-McCourt MD
    Breast Cancer Res; 2004; 6(5):R514-30. PubMed ID: 15318933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of transforming growth factor beta 1 on the growth of poorly and highly metastatic murine melanoma cells.
    Mooradian DL; Purchio AF; Furcht LT
    Cancer Res; 1990 Jan; 50(2):273-7. PubMed ID: 2295066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tenascin-C upregulates matrix metalloproteinase-9 in breast cancer cells: direct and synergistic effects with transforming growth factor beta1.
    Kalembeyi I; Inada H; Nishiura R; Imanaka-Yoshida K; Sakakura T; Yoshida T
    Int J Cancer; 2003 May; 105(1):53-60. PubMed ID: 12672030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of p21waf1 expression and growth inhibition by transforming growth factor beta involve the tumor suppressor gene DPC4 in human pancreatic adenocarcinoma cells.
    Grau AM; Zhang L; Wang W; Ruan S; Evans DB; Abbruzzese JL; Zhang W; Chiao PJ
    Cancer Res; 1997 Sep; 57(18):3929-34. PubMed ID: 9307274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.